Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its ...

Mars has hired David Jacobs as vp of marketing for its food and nutrition business in North America. The exec brings ...

Dustin Johnson's TaylorMade endorsement deal ended in 2024 and has not been extended, making the two-time major winner an ...

Dustin Johnson and TaylorMade end a lengthy run, bringing with it questions about the endorsement value of LIV players ...

(Reuters) - Johnson Controls International named Joakim Weidemanis as chief executive officer and lifted its 2025 profit ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

We recently published a list of 10 Best Stocks To Buy For Financial Stability. In this article, we are going to take a look ...

(To receive weekly emails of conversations with the world’s top CEOs and decisionmakers, click here.) It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to ...